Tadliq — Cigna
Pulmonary arterial hypertension (PAH) (WHO Group I)
Preferred products
- generic tadalafil tablets (20 mg)
- Alyq
Initial criteria
- Patient meets the standard Pulmonary Arterial Hypertension – Phosphodiesterase Type 5 Inhibitors Prior Authorization Policy criteria
- Patient meets ONE of the following: (i) Patient has tried Alyq or generic tadalafil 20 mg tablets; OR (ii) Patient cannot swallow or has difficulty swallowing Alyq or generic tadalafil 20 mg tablets; OR (iii) Patient requires administration of a dose that cannot be obtained with generic tadalafil 20 mg tablets
Approval duration
1 year